SERPINA3 is associated with a variety of metabolic disorders (e.g., non-alcoholic fatty liver disease, obesity, and atherosclerosis) through the regulation of inflammatory factor release and endothelial dysfunction. Here, SERPINA3 is linked to obesity disorder.